This blog is a collection of my favorite new treatments for basal cell carcinoma currently available through clinical trials. The start of each post contains a brief description of the approach, reasons I included it and a link to the trial website.

Vismodegib for Basal Cell Carcinoma

Vismodegib is an inhibitor of the hedgehog signaling pathway, a pathway involved in regulating adult stem cells that is over-active in more than 90% of basal cell carcinomas. This phase II clinical trial resulted in an increased progression free… [Learn More…]